Journal of Medicinal Chemistry Collection: Drug Discovery in Germany

Stefan Laufer,Matthias Gehringer,Alexander Titz

DOI: https://doi.org/10.1021/acs.jmedchem.4c00122

IF: 8.039

2024-02-03

Journal of Medicinal Chemistry

Abstract:J Med Chem . 2024 Feb 2. doi: 10.1021/acs.jmedchem.4c00122. Online ahead of print. NO

chemistry, medicinal

What problem does this paper attempt to address?

This document is not a research paper but an editorial article that mainly introduces the background and objectives of a special issue. This special issue focuses on articles published in the Journal of Medicinal Chemistry from 2020 to 2023 concerning the field of drug discovery in Germany.

From the content of the article, it attempts to address or explore the following aspects:

1. **The current state and changes in the field of drug discovery in Germany**: The article outlines significant changes in the German drug discovery field over the past 20 years, including the trend of consolidation and centralization within large pharmaceutical companies (Big Pharma), collaboration models with contract research organizations (CROs), and changes in academic research methods.

2. **The specialization process of academic drug discovery**: The article mentions that academic drug discovery projects have reached a fairly high level of specialization and have produced some candidate drugs that have entered clinical stages.

3. **The rise of small and medium-sized enterprises (SMEs) and academic spin-off companies in biotechnology**: These companies typically collaborate with CROs to advance their medicinal chemistry projects.

4. **Future development trends**: The article predicts future directions, including the continued consolidation of internal medicinal chemistry research and development within large pharmaceutical companies, the stable trend of translational research in academia, and the preference of public funding agencies for application-oriented projects.

By introducing these contents, the article aims to showcase the vitality of the German medicinal chemistry research community and the quality of its research outcomes. It also announces plans to invite original content for the publication of a virtual special issue focusing on young researchers.